These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1482 related items for PubMed ID: 10100525

  • 1. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 4. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 8. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E, Perez N.
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [Abstract] [Full Text] [Related]

  • 9. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Sep; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 11. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Feb; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 14. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T, Halmagyi GM, Yavor RA.
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT, Parnes LS.
    Am J Otol; 1999 May 28; 20(3):357-63. PubMed ID: 10337978
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS, Poe DS.
    Otol Neurotol; 2002 Jul 28; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [Abstract] [Full Text] [Related]

  • 19. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E, Zschaeck C, Gonzalez M, Mato T, Rodrigañez L, Barona R, Sanz R.
    Otol Neurotol; 2013 Oct 28; 34(8):1429-33. PubMed ID: 23722456
    [Abstract] [Full Text] [Related]

  • 20. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan 28; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.